1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:ROC curve analyses of CBFmax and rCBFmax in discriminating high- and low-grade gliomas
Parameters/Patients AUC Youden Index Cutoff Value Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%) CBFmax All 0.828 0.690 91 mL/100 g/min 84.4 84.6 95.0 61.1 84.5 Excludeda 0.859 0.829 91 mL/100 g/min 82.9 100 100 56.3 86.0 rCBFmax All 0.863 0.668 1.19 82.2 84.6 94.9 57.9 82.8 Excludeda 0.916 0.805 1.22 80.5 100 100 52.9 84.0
Note:—AUC indicates area under the curve; PPV, positive predictive value; NPV, negative predictive value.
↵a With oligodendrogliomas and anaplastic oligodendrogliomas excluded.